Mohsen Sohi - 15 Dec 2025 Form 4 Insider Report for Baker Hughes Co (BKR)

Reporting relationship: Director
Issuer ticker: BKR
Reported as of: 15 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Dec 2025, 16:22:27 UTC
Prior SEC filing: 12 Aug 2025
Next SEC filing: 21 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Fernando Contreras, Attorney-in-fact

Key filing fact

Mohsen Sohi filed Form 4 for Baker Hughes Co (BKR) on 17 Dec 2025.

Key facts

This page summarizes Mohsen Sohi's Form 4 filing for Baker Hughes Co (BKR).
5 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 17 Dec 2025, 16:22.

Change

Previous filing in this sequence was filed on 12 Aug 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001293588 Primary reporting owner

Sohi Mohsen

Relationship: Director
Address: 575 NORTH DAIRY ASHFORD ROAD, SUITE 100, HOUSTON
Signature: /s/ Fernando Contreras, Attorney-in-fact
Signature date: 17 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BKR transaction

Class A Common Stock

Options Exercise

Transaction value
Shares: +6,377
Change %
Price
Shares after: 6,377
Date: 15 Dec 2025
Ownership: Direct
Footnotes: F1

BKR transaction

Class A Common Stock

Options Exercise

Transaction value
Shares: +3,932
Change %: +62%
Price
Shares after: 10,309
Date: 15 Dec 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BKR transaction Derivative

Deferred Stock Units 12_25

Award

Transaction value
Shares: +3,448
Change %
Price
Shares after: 3,448
Date: 15 Dec 2025
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 3,448
Exercise price
Footnotes: F1, F2, F3

BKR transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares: -6,377
Change %: -100%
Price
Shares after: 0
Date: 15 Dec 2025
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 6,377
Exercise price
Footnotes: F1, F4

BKR transaction Derivative

Deferred Stock Unit

Options Exercise

Transaction value
Shares: -3,932
Change %: -100%
Price
Shares after: 0
Date: 15 Dec 2025
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 3,932
Exercise price
Footnotes: F1, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Each Deferred Stock Unit and each Restricted Stock Unit represents a right to receive without payment one share of Class A Common Stock of the Issuer.

Footnote F2

The amount reported in Column 5 includes 26.655 Deferred Stock Units received as dividend equivalents.

Footnote F3

The Deferred Stock Units were fully vested on the date of grant, December 15, 2025. Pursuant to the Issuer's Non-Employee Director Deferral Plan, the reporting person elected to receive their 2025 retainer fees in stock and to defer delivery of the shares until the date the reporting person ceases to serve as a director.

Footnote F4

The reported transaction represents the receipt of shares in settlement of fully vested Restricted Stock Units granted on May 16, 2023, for which the reporting person previously elected, pursuant to the Issuer's Non-Employee Director Deferral Plan, to defer settlement until December 15, 2025.

Footnote F5

The reported transaction represents the receipt of shares in settlement of fully vested Deferred Stock Units granted on December 15, 2023 in respect of 2023 retainer fees that the reporting person previously elected to receive in stock with settlement deferred, pursuant to the Issuer's Non-Employee Director Deferral Plan, until December 15, 2025.